InMed Pharmaceuticals Inc.
INM
$1.50
-$0.03-1.96%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.54M | -5.54M | -6.09M | -6.04M | -6.19M |
| Total Depreciation and Amortization | 445.80K | 445.80K | 416.90K | 405.20K | 426.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 177.60K | 177.60K | 118.60K | 131.20K | 162.60K |
| Change in Net Operating Assets | -842.30K | -842.30K | -333.40K | -602.60K | 243.90K |
| Cash from Operations | -5.76M | -7.42M | -7.55M | -7.77M | -7.02M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.79M | 8.79M | 9.19M | 10.22M | 1.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -756.60K | -756.60K | -814.20K | -868.80K | -249.40K |
| Cash from Financing | 8.04M | 10.96M | 11.30M | 12.27M | 4.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.28M | 3.54M | 3.75M | 4.50M | -2.92M |